T

Travere Therapeutics
D

TVTX

25.620
USD
0.46
(1.81%)
مفتوح الان
حجم التداول
6,177
الربح لكل سهم
-1
العائد الربحي
-
P/E
-13
حجم السوق
2,283,732,802
أصول ذات صلة الأخبار المقالات

العنوان: Travere Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.